Search results
Is Ulcerative Colitis Curable, or Is Symptom Remission Possible?
Verywell Health via Yahoo News· 6 months agoUlcerative colitis (UC) is a chronic inflammatory bowel disease (IBD). There is no known cure for...
Pfizer Has a New Oral Pill for Ulcerative Colitis
Verywell Health via Yahoo News· 6 months agoThe FDA approved Velsipity (etrasimod), a drug by Pfizer to treat ulcerative colitis. The approval adds another treatment option for patients who respond...
Is Ulcerative Colitis an Autoimmune Disease?
Verywell Health via Yahoo News· 3 months agoMedically reviewed by Jay N. Yepuri, MD Ulcerative colitis is a type of inflammatory bowel disease (IBD). A problem with the immune system leads to...
What Is Ulcerative Colitis?
Health via Yahoo News· 2 months agoUlcerative colitis is a type of inflammatory bowel disease (IBD) that inflames the colon and rectum and causes symptoms like abdominal pain and diarrhea.
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 1 week agoTakeda Pharmaceutical Co. Ltd. (NYSE:TAK) is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins...
The Surprise That Prompted Morphic Therapeutic To Dump 55% Over Two Days
Investor's Business Daily· 7 months agoMorphic Therapeutic stock plummeted Monday after tests showed the company's ulcerative colitis drug...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoTakeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript October 27, 2023...
Takeda Pharmaceutical’s Third-Quarter Net Profit Dropped on Lower Margins
The Wall Street Journal· 3 months agoNEWSPLUS Takeda Pharmaceutical reported a drop in its third-quarter net profit due partly to lower...
Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 billion
Reuters via Yahoo News· 1 year agoThe drug, codenamed "NDI-034858", last week showed statistically significant reduction in...
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
Benzinga via Yahoo Finance· 11 months agoThe FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active...
